Abstract
Mutations in PCSK1 cause monogenic obesity. To assess the contribution of PCSK1 to polygenic obesity risk, we genotyped tag SNPs in a total of 13,659 individuals of European ancestry from eight independent case-control or family-based cohorts. The nonsynonymous variants rs6232, encoding N221D, and rs6234-rs6235, encoding the Q665E-S690T pair, were consistently associated with obesity in adults and children (P = 7.27 × 10−8 and P = 2.31 × 10−12, respectively). Functional analysis showed a significant impairment of the N221D-mutant PC1/3 protein catalytic activity.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Prohormone convertase 1/3 deficiency causes obesity due to impaired proinsulin processing
Nature Communications Open Access 13 August 2022
-
Angeborene Adipositasformen und Therapien
Journal für Klinische Endokrinologie und Stoffwechsel Open Access 23 September 2021
-
A review on association and correlation of genetic variants with eating disorders and obesity
Future Journal of Pharmaceutical Sciences Open Access 26 May 2021
Access options
Subscribe to Journal
Get full journal access for 1 year
$79.00
only $6.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.

References
Hager, J. et al. Nat. Genet. 20, 304–308 (1998).
Chagnon, Y.C. et al. J. Appl. Physiol. 90, 1777–1787 (2001).
Bell, C.G. et al. Diabetes 53, 1857–1865 (2004).
Chen, G. et al. Int. J. Obes. (Lond.) 29, 255–259 (2005).
Jackson, R.S. et al. Nat. Genet. 16, 303–306 (1997).
Jackson, R.S. et al. J. Clin. Invest. 112, 1550–1560 (2003).
Farooqi, I.S. et al. J. Clin. Endocrinol. Metab. 92, 3369–3373 (2007).
Balkau, B. Rev. Epidemiol. Sante Publique 44, 373–375 (1996).
Zhou, Y. & Lindberg, I. J. Biol. Chem. 269, 18408–18413 (1994).
Lloyd, D.J., Bohan, S. & Gekakis, N. Hum. Mol. Genet. 15, 1884–1893 (2006).
Author information
Authors and Affiliations
Contributions
M.B. was responsible for the study design, project follow-up and statistical analysis, was involved in the in vitro study and wrote the manuscript. J.W.M.C. was responsible for the in vitro study. H.C. was involved in the in vitro study. S.L., E.D. were involved in the genotyping. C.D. was involved in the statistical analysis. A.G. was involved in the sequencing. P.B. was involved in the study design. B.J., B.H., B.B., J.T., M.M., N.P. provided the DNA and quantitative data for the D.E.S.I.R. study. F.H. provided the DNA and quantitative data for the Swiss study. C.L.S. and S.C. provided the DNA and quantitative data for the second French children obesity study. W.K., A.K. and P.K. provided the DNA and quantitative data for the German study. P.J. and L.M.S.C. provided the DNA and quantitative data for the Swedish study. A.J.W. helped draft the manuscript. A.S., T.L., K.B.-J., G.A., T.J., T.H. and O.P. provided the DNA and quantitative data for the Danish case-control study. D.M. was involved in the study design and helped draft the manuscript. P.F. was the principal investigator on the project was involved in the study design, data analyses and in the manuscript writing.
Corresponding author
Supplementary information
Supplementary Text and Figures
Supplementary Methods, Supplementary Figure 1, Supplementary Tables 1–6 (PDF 923 kb)
Rights and permissions
About this article
Cite this article
Benzinou, M., Creemers, J., Choquet, H. et al. Common nonsynonymous variants in PCSK1 confer risk of obesity. Nat Genet 40, 943–945 (2008). https://doi.org/10.1038/ng.177
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.177
This article is cited by
-
Prohormone convertase 1/3 deficiency causes obesity due to impaired proinsulin processing
Nature Communications (2022)
-
Testing for rare genetic causes of obesity: findings and experiences from a pediatric weight management program
International Journal of Obesity (2022)
-
The promise of new anti-obesity therapies arising from knowledge of genetic obesity traits
Nature Reviews Endocrinology (2022)
-
A review on association and correlation of genetic variants with eating disorders and obesity
Future Journal of Pharmaceutical Sciences (2021)
-
Angeborene Adipositasformen und Therapien
Journal für Klinische Endokrinologie und Stoffwechsel (2021)